Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_assertion type Assertion NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_head.
- NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_assertion description "[Chga mice displayed extreme phenotypic changes, including: (a) decreased chromaffin granule size and number; (b) elevated BP; (c) loss of diurnal BP variation; (d) increased left ventricular mass and cavity dimensions; (e) decreased adrenal catecholamine, neuropeptide Y (Npy), and ATP contents; (f) increased catecholamine/ATP ratio in the chromaffin granule; and (g) increased plasma catecholamine and Npy levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_provenance.
- NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_assertion evidence source_evidence_literature NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_provenance.
- NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_assertion SIO_000772 16007257 NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_provenance.
- NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_assertion wasDerivedFrom befree-20140225 NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_provenance.
- NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_assertion wasGeneratedBy ECO_0000203 NP566439.RAcFufC-CIWT-IAksB1Jc5tzI0_yXNiR8epSQyoCvGfxU130_provenance.